ROLE OF FIBRIN SEALANT IN PREVENTION OF HANGING PALATE OUR EXPERIENCE. Elankumar S, Chittoria R K *
|
|
- Brandon McCoy
- 6 years ago
- Views:
Transcription
1 Plastic Surgery Case Report International Journal of Clinical And Diagnostic Research ISSN Volume 6, Issue 2, Mar-April 2018 ROLE OF FIBRIN SEALANT IN PREVENTION OF HANGING PALATE OUR EXPERIENCE Elankumar S, Chittoria R K * Abstract Hanging palate is one of the rare complications of cleft palate surgery, where the sutured palatal mucoperiosteal flaps dehisced from the sutured anterior alveolar margin. Though secondary suturing is one of the options to treat this complication, secondary surgery which increases the morbidity should be prevented. Conventionally obturator placement following surgery has been described. Here we are sharing our idea of using fibrin sealant for preventing the complication of hanging palate. Author Affiliations: Department of Plastic Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India Keywords: Hanging palate, fibrin sealant, cleft palate complications *Corresponding Author: Dr Ravi Kumar Chittoria MS, MCh, DNB, MNAMS, PhD, MBA, PGDTM, PDCR, PGDMLS Professor & Registrar (Academic) Department of Plastic Surgery JIPMER, Pondicherry, India. drchittoria@yahoo.com Mobile cleft lip with palate ranges between per INTRODUCTION India is one of the most populous country in the world, having approximately 25 million births per year. 1 Incidence of cleft palate and 1000 live births in India. [1,2] Various surgical techniques have been described for cleft palate repair. [3-9] These include techniques for closing hard palate, soft palate and protocol based
2 techniques. [3,10] Optimal timing for undergoing cleft palate surgery is considered between 6-12 months. [11,12] Complications of cleft palate surgery include perioperative bleeding, fistula, wound dehiscence, infection, flap necrosis, hanging palate and other late complications.[ 3,13] Hanging palate is the term coined by Dr.Karoon Agrawal caused by the anterior wound dehiscence resulting in the detachment of mucoperiosteal flap anteriorly with intact attachment posteriorly. This may result from infection, seroma or hematoma collection in the dead space, poor surgical techniques. [14] This may resultin large raw area and oronasal fistula. [3] Secondary suturing may done for treating this complication which causes additional morbidity to the child. We are sharing our idea of applying fibrin sealant in the dead space between oral and nasal layers of palatal mucoperiosteal flaps to prevent this complication. underwent Bardach two flap palatoplasty. After closing the nasal layer( with or without vomerine flaps) oral mucoperiosteal layers sutured in midline and anteriorly to the alveolar region, about 1 ml of freshly prepared fibrin sealant injected into the dead space laterally through gap between mucoperiosteal layer and bony palatal shelf as shown in Figure-1. Followed by compression was given for five minutes and the remaining lateral raw areas sutured. Patients were admitted post operatively for seven days and followed up. Liquid diet was started on the day of surgery. Post operatively antibiotic cover was given for three days. All the patient s wounds were healed completely. There was no evidence of infection. METHODOLOGY: This study was conducted in the Department of Plastic Surgery, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry during the period between November 2014 and July Prospectively fifteen consecutive type II and III cleft (Nagpur classification) patients of all age group were included in the study who Figure 1: Fibrin sealant injected into the dead space laterally through gap between mucoperiosteal layer and bony palatal shelf
3 DISCUSSION: Hanging palate can be prevented by avoiding or obliterating the dead space under the mucoperiosteal flap by good haemostasis, and good approximation of the mucoperiosteal flap with the sutured nasal mucosa and by the prevention of infection. [15] Fibrin sealant is a complex plasma-derived product which is increasingly used as a biodegradable tissue adhesive or sealant to stop or control bleeding or provide air and fluid tightness in many surgical situations. [16] Bergel in 1909 first used the fibrinogen and fibrin as the haemostatic agent. Currently available fibrin sealants are based on a two-componentmixture, comprised of a fibrinogen and a thrombin concentrate produced from human plasma. The fibrinogen and thrombin components are usually freezedried. They should be solubilized, prior to use, with solutions of aprotinin(fibrinogen) and calcium chloride(thrombin). The mixing of the two components, carried out in the presence of ionized calcium, produces the gradual polymerization of fibrinogen to fibrin which in combination with platelets cause clots and achieves hemostasis. [16] The two components fibrin sealant usually applied simultaneously with dual syringe system as shown in Fig- 2. Figure 2: Components of fibrin sealant applied simultaneously with dual syringe system It has been used for numerous purposes in surgical repairs: tissue adhesion, haemostatic agent, fluid barrier and space-filling growth matrix etc. [17,18,20] Fibrin sealant is used in almost all surgical specialities. [16] All the above-mentioned properties are in favour of using fibrin sealant for obliterating the dead space between the mucoperiosteal oral and nasal layer and possibly prevents the separation of oral mucoperiosteal layer from the nasal layer and bony palatal shelves. We found in all 15 patients wound healed completely without any complications. Veena Singh et al have described similar experience for the prevention of hanging palate. [19]
4 CONCLUSION Though hanging palate is a relatively rare complication of cleft palate surgery, treatment will be cumbersome and may cause added morbidity if the complication occurs. Here we have shared our idea and experience of using fibrin sealant for possible prevention of hanging palate. As the sample size in this study is small further large randomised control study is required to validate the same. Conflict of Interest Statement- There is no conflict of interest. REFERENCES: 1. Mossey P, Little J. Addressing the challenges of cleft lip and palate research in India. Indian Journal of Plastic Surgery ;42(3):9. 2. Reddy SG, Reddy RR, Bronkhorst EM, Prasad R, Ettema AM, Sailer HF, Bergé SJ. Incidence of cleft lip and palate in the state of Andhra Pradesh, South India. Indian journal of plastic surgery. 2010;43(2): Agrawal K. Cleft palate repair and vari ations.indian J Plast Surg 2009;42: Bardach J. Two-flap palatoplasty: Bardach s technique. Operative Techniques Plast Surg. 1995;2: Dorrance GM, Bransfield JW. The pushback operation for repair of cleft palate. Plast Reconstr Surg. 1946;1: Hellquist R. Team work and clinical research in the treatment of cleft lip and palate. Sven TandlakTidskr. 1973;66: Kaplan EN. Soft palate repair by levator muscle reconstruction and a buccal mucosal flap. Plast Reconstr Surg. 1975;56: Cronin T D. Method of preventing raw areas on the nasal surface of soft palate in push-back surgery. Plast Reconstr Surg. 1957;20: FurlowJr LT. Cleft palate repair by double opposing Z-plasty. Plast Reconstr Surg. 1986;78: Schweckendiek W. Primary veloplasty. In: Schuchardt K, editor. Treatment o f patients with clefts of lip, alveolus and palate. Stuttgart: G Thieme; Chapman KL, Hardin MA. Phonetic and phonologic skills of two-year-olds with cleft palate. Cleft Palate Craniofac J. 1992;29:
5 12. Dorf DS, Curtin JW. Early cleft palate repair and speech outcome. Plast Reconstr Surg. 1982;70: Schönmeyr B, Wendby L, Campbell A. Surgical complications in 1408 primary cleft palate repairs operated at a single center in Guwahati, Assam, India. The Cleft Palate-Craniofacial Journal. 2016;53(3): Dufresne CR. Oronasal and nasolabial fistulas. In: Bardach J, Morris HL, editors. Multidisciplinary Management of Cleft Lip and Palate. Philadelphia: Saunders; p Agrawal K, Panda KN. An innovative management of detached palatal mucoperiosteal flap from the hard palate (hanging palate). Plastic and reconstructive surgery. 2005;115(3): Radosevich M, Goubran HA, Burnouf T. Fibrin sealant: scientific rationale, production methods, properties, and current clinical use. Voxsanguinis Apr 1;72(3): Sierra DH: Fibrin sealant adhesive systems: A review of their chemistry, material properties and clinical applications. J BiomaterAppl 1993;7: Spotnitz WD: Fibrin sealant in the United States: Clinical use at the University of Virginia. ThrombHaemost 1995;74: Singh V, Singh AK, Kumar V. Use of fibrin sealant in prevention of hanging palate: A rare complication after cleft palate surgery. Journal of Cleft Lip Palate and Craniofacial Anomalies. 2015;2(1): Hemantkumar S, Nandhagopal V, Mohapatra DP, Thiruvoth FM, Sivakumar DK, Chittoria RK. Application of Fibrin Sealant in Cleft Palate Surgery. NIJS. 2010:23.
Surgical Adhesives in Facial Plastic Surgery
Surgical Adhesives in Facial Plastic Surgery Dean M. Toriumi, Victor K. Chung, Quintin M. Cappelle University of Illinois at Chicago Chicago, IL Supplement to Toriumi DM, Chung VK, Cappelle QM. Surgical
More informationA Systematic Review Comparing Furlow Double- Opposing Z-Plasty and Straight-Line Intravelar Veloplasty Methods of Cleft Palate Repair
PEDIATRIC/CRANIOFACIAL A Systematic Review Comparing Furlow Double- Opposing Z-Plasty and Straight-Line Intravelar Veloplasty Methods of Cleft Palate Repair Mary Roz Timbang, B.A. Bahar Bassiri Gharb,
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
European Medicines Agency Evaluation of Medicines for Human Use London, 29 July 2004 CPMP/BPWG/1089/00 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE CLINICAL INVESTIGATION OF PLASMA
More informationALLODERM SELECT ALLODERM SELECT RESTORE
ALLODERM SELECT ALLODERM SELECT RESTORE Regenerative Tissue Matrix Instructions for Use Processed from donated human tissue by: LifeCell Corporation One Millennium Way Branchburg, NJ 08876-3876 DESCRIPTION
More informationDiscover TruPRP. PRP the way you want it.
Discover TruPRP PRP the way you want it. Discover TruPRP Discover the quality of Magellan TruPRP. The Magellan technology provides an automated dual spin processing system that can deliver (PRP) Platelet
More informationHistoacryl A revolution in mesh fixation
Histoacryl A revolution in mesh fixation Closure Technologies Histoacryl A revolution in mesh fixation A new indication for a classic product Histoacryl has been used for more than 40 years in operating
More informationThe Power in You. TM
RegenKit THT Autologous Platelet Rich Plasma (A-PRP) The Power in You. TM Biologics Concentrated on Healing RegenKit THT Autologous Platelet Rich Plasma (A-PRP) The RegenKit THT is designed to be used
More informationAsk your surgeon for more information about Natrelle and visit GummyImplants.com
The #1 surgeon-preferred gummy implant collection in the US* Two-stage breast reconstruction starts with Natrelle 133 Series Tissue Expanders Natrelle 133 Series Tissue Expanders are made to match Natrelle
More informationBAXTER UNVEILS DESIGN ENHANCEMENTS TO FLOSEAL AND TISSEEL HEMOSTATIC AGENTS AT AORN MEETING
FOR IMMEDIATE RELEASE Media Contact Beth Mueller, (224) 948-5353 media@baxter.com Investor Contact Clare Trachtman, (224) 948-3085 BAXTER UNVEILS DESIGN ENHANCEMENTS TO FLOSEAL AND TISSEEL HEMOSTATIC AGENTS
More informationThe Rate of Oronasal Fistula Following Primary Cleft Palate Surgery: A Meta-Analysis
The Cleft Palate Craniofacial Journal 52(4) pp. e81 e87 July 2015 Ó Copyright 2015 American Cleft Palate Craniofacial Association ORIGINAL ARTICLE The Rate of Oronasal Fistula Following Primary Cleft Palate
More informationThe role of autologous fibrin-platelet glue in plastic surgery: A preliminary report
The International Journal of Artificial Organs / Vol. 25 / no. 4, 2002 / pp. 334-338 New Trends The role of autologous fibrin-platelet glue in plastic surgery: A preliminary report M. VALBONESI 1, G. GIANNINI
More informationScottish Medicines Consortium
Scottish Medicines Consortium fondaparinux, 2.5mg/0.5ml, solution for injection (Arixtra ) No. (287/06) GlaxoSmithKline 7 July 2006 The Scottish Medicines Consortium has completed its assessment of the
More informationSession 1 Topics. Vascular Phase of Hemostasis. Coagulation Pathway. Action of Unfractionated Heparin. Laboratory Monitoring of Anticoagulant Therapy
~~Marshfield Labs Presents~~ Laboratory Monitoring of Anticoagulant Therapy Session 1 of 4 Session 1 Topics Review of coagulation and the vascular phase of hemostasis Unfractionated heparin Low molecular
More informationTRELLIS COLLAGEN RIBBON
TRELLIS COLLAGEN RIBBON 147321-1 English (en) The following languages are included in this packet: M Wright Medical Technology, Inc. 5677 Airline Rd. Arlington, TN 38002 USA www.wmt.com August 2012 Printed
More informationDuraGen Secure. Dural Regeneration Matrix
DuraGen Secure Dural Regeneration Matrix DESCRIPTION DuraGen Secure Dural Regeneration Matrix is an absorbable implant for the repair of dural defects. DuraGen Secure Dural Regeneration Matrix is an easy
More informationSection 8. To introduce the basic theory and principles of collecting blood for Intraoperative Cell Salvage (ICS)
Section 8 Practicalities Blood Collection Aim To introduce the basic theory and principles of collecting blood for Intraoperative Cell Salvage (ICS) Learning Outcomes To identify the equipment used for
More informationThe Use of Autologous Platelet-Rich Plasma (Platelet Gel) and Autologous Platelet-Poor Plasma (Fibrin Glue) in Cosmetic Surgery
PLASTIC & RECONSTRUCTIVE SURGERY. 2001 Jan; 107(1):229-37; discussion 239-9. The Use of Autologous Platelet-Rich Plasma (Platelet Gel) and Autologous Platelet-Poor Plasma (Fibrin Glue) in Cosmetic Surgery
More informationCoagulation in perspective: Blood management. Objectives
Coagulation in perspective: Blood management Julie Wegner, PhD jawrbl@gmail.com Objectives To gain a basic understanding of the following: 1. Coagulation components and processes Why patients bleed. 2.
More informationROLE OF TISSUE ADHESIVE IN OTORHINOLARYNGOLOGY
From the SelectedWorks of Balasubramanian Thiagarajan August 1, 2012 ROLE OF TISSUE ADHESIVE IN OTORHINOLARYNGOLOGY Balasubramanian Thiagarajan Karthikeyan Arjunan Seethalakshmi Narashiman Available at:
More informationPresenting SURGICEL Powder
SURGICEL Powder Presenting SURGICEL Powder Built to stop continuous, broad-surface oozing fast1,2 The next generation of SURGICEL Absorbable Hemostats SURGICEL Powder efficiently and effectively controls
More informationBAXTER HEALTHCARE v JOHNSON & JOHNSON WOUND MANAGEMENT
CASE AUTH/2107/3/08 BAXTER HEALTHCARE v JOHNSON & JOHNSON WOUND MANAGEMENT Promotion of Quixil fibrin sealant Baxter Healthcare alleged that Johnson & Johnson Wound Management s use of a regulatory authority
More informationPREVELEAK Surgical sealant
PREVELEAK Surgical sealant Rx only Instructions for Use DEVICE DESCRIPTION PREVELEAK Surgical sealant (PREVELEAK) is a sealant developed to seal suture holes formed during surgical repair of the circulatory
More informationContinuous External Tissue Expander
Continuous External Tissue Expander Facilitates rapid tissue movement to automatically reduce or re-approximate wounds Never needs re-tightening after initial application! 1 Potential Annual Hospital Cost
More informationRed Cell Transfusion LESSONS FROM TRAUMA
Red Cell Transfusion LESSONS FROM TRAUMA Sandro Rizoli, MD PhD FRCSC FACS Professor Surgery & Critical Care Medicine Trauma Program Director Chair Trauma Care Disclosure KCI Canada CSL Behring NovoNordisk
More informationCapSure Permanent Fixation System
CapSure Permanent Fixation System Permanent Fixation Redefined Advancing the Fixation Experience Recipient of 2015 SLS Innovations of the Year recognition. SOFT TISSUE REPAIR Right Procedure. Right Product.
More informationA 6.6 ml aliquot of whole physiological native blood was taken directly from the patient and
Supplemental 1 Gel Point Measurement A 6.6 ml aliquot of whole physiological native blood was taken directly from the patient and loaded into a double-gap concentric cylinder of a TA Instruments AR-G2
More informationGuideline on core SmPC for plasma-derived fibrin sealant/ haemostatic products
1 2 3 18 December 2013 EMA/CHMP/BPWP/598816/2010 rev. 1 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 Guideline on core SmPC for plasma-derived fibrin sealant/ haemostatic products Draft
More informationThe Clinical Use and Immunologic Impact of Thrombin in Surgery
The Clinical Use and Immunologic Impact of Thrombin in Surgery Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical Center Durham, North Carolina Bovine Thrombin
More informationRegenACR. autologous cellular regeneration. RegenACR A-PRP treatment. collagen fibers. 1,2 texture and elasticity. 3 volume & strength.
RegenACR autologous cellular regeneration RegenACR A-PRP treatment collagen fibers. 1,2 texture and elasticity. 3 volume & strength. 4,5 WHAT IS A-PRP Autologous Platelet Rich Plasma Plasma contains many
More informationSTEM CELLS BONE FRACTURE
BIOLOGY UNIT 2 MRS. CATHERINE JACKSON STEM CELLS BONE FRACTURE By AYESHA SYED 10C 2 Stem Cell (Introduction) Stem cells are undifferentiated cells that have not yet become a specialised cell, with a specific
More informationArthrex Angel TM System. Indication-specific PRP and PRF gel preparations
Arthrex Angel TM System Indication-specific PRP and PRF gel preparations Arthrex Angel TM System The Arthrex Angel TM System is a revolutionary production system for platelet-rich plasma (PRP) formulations
More informationThese handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides.
These handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides. If you would like the 1 slide per page handouts, please ask
More informationImproving Outcomes of Cardiac Surgery with a Point-of-Care Based Transfusion Algorithm
Improving Outcomes of Cardiac Surgery with a Point-of-Care Based Transfusion Algorithm Summer Syed (local PI) Keyvan Karkouti Deputy Anesthesiologist-in-Chief, Toronto General Hospital, University Health
More informationLABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY
LABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY 1 WHEN IS THE LAB REQUIRED TO INVESTIGATE FOR A POSSIBLE BLEEDING DISORDER? Clinically suspected bleeding tendency
More informationHEMOSTASIS IN SURGERY
Greco D.P.- M.D.-F.A.C.S. Director SSD Day Surgery Torino 25-27 november 2010 HEMOSTASIS IN SURGERY The normal physiological response that prevents significant blood loss following vascular injury is called
More informationLINC James F. McKinsey, M.D.
Two-Year Evaluation of Fenestrated and Parallel Branch Endografts for the Treatment of Juxtrarenal, Suprarenal and Thoracoabdominal Aneurysms at a Single Institution LINC 2018 James F. McKinsey, M.D. The
More informationPRP Preparation. Simplicity for Success
PRP Preparation Simplicity for Success Features and Benefits of the Tropocells System Effectiveness Enables high platelet concentration by reducing the volume of plasma. Rapid and simple one step process
More informationThe Ventrio ST Hernia Patch Featuring Sepra Technology. Efficient:
Ventrio ST Hernia Patch featuring SEPRA Technology NEW Sepra Technology Based on the technology used in Seprafilm with more than 13 years of proven clinical success. Unique hydrogel barrier swells to minimise
More information"Release of growth factors in PRP activated with thrombin."
"Release of growth factors in PRP activated with thrombin." Carrasco, Joaquin phd Dp. Surgery Universitat de València. Presenter Bonete, Daniel MD Hospital La Fe de València Gomar, Francisco MD Hospital
More informationAdhesive Use in Oral and Maxillofacial Surgery
Adhesive Use in Oral and Maxillofacial Surgery Michael J. Buckley, DMD, MBA, MS a,b, *, Eric J. Beckman, PhD c,d KEYWORDS Tissue adhesives Adhesives for bone fixation Cyanoacrylates Fibrin sealants Collagen-based
More informationDEPARTMENT OF CLINICAL LABORATORY SCIENCES SCHOOL OF HEALTH TECHNOLOGY AND MANAGEMENT THE UNIVERSITY AT STONY BROOK STONY BROOK, NEW YORK
DEPARTMENT OF CLINICAL LABORATORY SCIENCES SCHOOL OF HEALTH TECHNOLOGY AND MANAGEMENT THE UNIVERSITY AT STONY BROOK STONY BROOK, NEW YORK 11794-8205 COAGULATION COMPETENCY EVALUATION FORM STUDENT NAME:
More informationPRODUCT MONOGRAPH ARTISS. Fibrin Sealant (Human), Vapor Heated, Solvent/Detergent Treated 4 IU (Slow Set)
PRODUCT MONOGRAPH Pr ARTISS Fibrin Sealant (Human), Vapor Heated, Solvent/Detergent Treated 4 IU (Slow Set) Frozen Solutions for Thawing for Topical Application Hemostatic and Tissue Adhesive Agent Baxter
More informationCAUTION: U.S. Federal law restricts this device to sale by or on the order of a licensed physician.
TM CAUTION: U.S. Federal law restricts this device to sale by or on the order of a licensed physician. TABLE OF CONTENTS Section Port Styles 4 Description 5 Indications 5 Contraindications 5-6 Information
More information2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Active substances Human fibrinogen, Coagulation Factor XIII (human), Aprotinin (bovine)
1. NAME OF THE MEDICINAL PRODUCT 0.5 ml, 1 ml, 3 ml Powders and solvents for sealant. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Qualitative composition Combi-Set I: Active substances Human fibrinogen,
More informationICU. Recovery. Plus Ultrasound-guided mechanical ventilation, F. Mojoli & S. Mongodi MANAGEMENT & PRACTICE
ICU MANAGEMENT & PRACTICE VOLUME 17 - ISSUE 3 - AUTUMN 2017 CSL Behring Supplement from Euroanaesthesia 2017 Symposium Recovery The role of autophagy in the metabolism and outcomes after surgery, J. Gunst
More informationKey Issues in Plastic and Cosmetic Surgery Vol. 16
Key Issues in Plastic and Cosmetic Surgery Vol. 16 Key Issues in Plastic and Cosmetic Surgery Vol. 16 (by the editorial board of the series previously known as Advances in Plastic and Reconstructive Surgery
More informationEach TISSEEL Lyo contains 4 vials. The active ingredients are:
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT TISSEEL Lyo Two-Component Fibrin Sealant 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each TISSEEL Lyo contains 4 vials. The active ingredients
More informationPhysiology Unit 3 HEMATOLOGY
Physiology Unit 3 HEMATOLOGY In Physiology Today Hematocrit Percentage of blood volume that is erythrocytes 45% in men 42% in women Average blood volume in is 5 L Plasma Large amounts of organic/inorganic
More informationGuideline on core SmPC for human fibrinogen products
23 July 2015 EMA/CHMP/BPWP/691754/2013 Rev 1 Committee for Medicinal Products for Human Use (CHMP) Draft Agreed by Blood Products Working Party 27 November 2013 Adoption by CHMP for release for consultation
More informationEFFECT OF FIBRIN GLUE DERIVED FROM SNAKE VENOM ON THE VIABILITY OF AUTOGENOUS SPLIT-THICKNESS SKIN GRAFT
Received: May 9, 2003 J. Venom. Anim. Toxins incl. Trop. Dis. Accepted: August 4, 2003 V.10, n.2, p.161-172, 2004. Published online: June 5, 2004 Original paper - ISSN 1678-9199. EFFECT OF FIBRIN GLUE
More informationFASTER, SAFER, SIMPLER SURGERY. Terrence Norchi, M.D. President - CEO OTCQB: ARTH
FASTER, SAFER, SIMPLER SURGERY Terrence Norchi, M.D. President - CEO 1 OTCQB: ARTH Cautionary Statement Regarding Forward-Looking Statements This presentation includes forward-looking statements. We make
More informationHydroSet. Injectable HA Bone Substitute
HydroSet Injectable HA Bone Substitute The Latest Advancement in Bone Substitute Technology Fast Setting Injectable or Manual Implantation Osteoconductive Excellent Wet-field Characteristics Isothermic
More informationPlatelet Concentrate in Total Knees BIOLOGICS. This brochure is for International use only. It is not for distribution in the United States.
Platelet Concentrate in Total Knees BIOLOGICS This brochure is for International use only. It is not for distribution in the United States. Platelet Concentrate in Total Knees Total Knee Arthroplasty Total
More informationSpecialty Needles and Surgical Products Range Hill-Rom is a leading global medical technology company with more than 10,000 employees in over 100 countries. We partner with health care providers by focusing
More informationARTISS. NAME OF THE MEDICINE Two-Component Fibrin Sealant, Deep-Frozen, Vapour Heated (VH) and Solvent Detergent (S/D) treated.
ARTISS NAME OF THE MEDICINE Two-Component Fibrin Sealant, Deep-Frozen, Vapour Heated (VH) and Solvent Detergent (S/D) treated. DESCRIPTION ARTISS is a two-component fibrin sealant made from pooled human
More information-- Laki J. Rousou, MS, MD et. al. -- Boston, Massachusetts. -- Ann Thorac Surg 2009;87:62 70.
-- Laki J. Rousou, MS, MD et. al -- Boston, Massachusetts. -- Ann Thorac Surg 2009;87:62 70. Presented by: Int. 黃柏翔 Date: 2009 /02 / 25 Patient outcome after CABG surgery greatly influenced by patency
More informationThe Coagulation Workup In The Office Setting
CAA Conference alm Springs 2012 The Coagulation Workup In The Office Setting CAA Conference alm Springs, October 2012 Robert Miller, A-C Henoch-Schoenlein urpura 1 CAA Conference alm Springs 2012 2 CAA
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #21 (NQF 0268): Perioperative Care: Selection of Prophylactic Antibiotic First OR Second Generation Cephalosporin National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL
More informationDIRECTIONS FOR USE. NATRELLE 133 Plus Tissue Expanders. MAGNA-FINDER Xact. Directions for Use. with Magna-Site. Injection Sites
DIRECTIONS FOR USE Directions for Use NATRELLE 133 Plus Tissue Expanders with Magna-Site Injection Sites MAGNA-FINDER Xact & 21G Needle Infusion Set CAUTION: U.S. Federal law restricts this device to sale
More informationMIIG INJECTABLE Graft The following languages are included in this packet:
MIIG INJECTABLE Graft 128801-10 The following languages are included in this packet: English (en) Deutsch (de) Nederlands (nl) Français (fr) Español (es) Italiano (it) Português (pt) 中文 - Chinese (sch)
More informationLaryngeal Soft Tissue Fixation Device
May 2011 Laryngeal Soft Tissue Fixation Device Ross Comer, Bryan Jepson, Christa Wille, William Zuleger Client: Dr. Seth Dailey, UW School of Medicine and Public Health Advisor: Professor John Webster,
More informationLVHN Scholarly Works. Lehigh Valley Health Network. Joseph G. Ottinger RPh, MS, MBA, BCPS Lehigh Valley Health Network,
Lehigh Valley Health Network LVHN Scholarly Works Department of Pharmacy Retrospective Evaluation of Delayed Administration of Fondaparinux in Providing Comparable Safety and Efficacy Outcomes in Patients
More informationBIP Central Venous Catheter
Bactiguard Infection Protection BIP Central Venous Catheter For prevention of healthcare associated infections Bactiguard benefits Reduced healthcare costs Reduced use of antibiotics Save lives Bloodstream
More informationDisclosures. Thromboelastography. TEG Methodology. TEG Output. Thromboelastography (TEG): Basics & Clinical Applications
Thromboelastography (TEG): Basics & Clinical Applications Paula J. Santrach MD Associate Professor, Laboratory Medicine Mayo Clinic Rochester, MN Disclosures Relevant financial relationships NONE Off label
More informationCommon Inherited Bleeding Disorders
CAA 2015 Annual Conference Common Inherited Bleeding Disorders Bob Miller, A October 8, 2015 VWF has two jobs Loosely bound to protect FVIII and tether to site of injury All other coagulation factors also
More informationPolicies Concerning Survival Surgery of Mice
Policies Concerning Survival Surgery of Mice Date approved: October 25, 2016 Purpose This document details the minimum standards for survival (recovery) surgery in all laboratory rodent species. Responsibility
More informationCADTH ISSUES IN EMERGING HEALTH TECHNOLOGIES
CADTH ISSUES IN EMERGING HEALTH TECHNOLOGIES Informing Decisions About New Health Technologies Issue 162 July 2017 Patient-Controlled Carbon Dioxide Tissue Expansion for Breast Reconstruction Image courtesy
More informationUnderstanding Clinical Equivalence
Understanding Clinical Equivalence BSI 2014 Medical Device Mini-Roadshow Ibim Tariah Ph.D Technical Director, Healthcare Solutions 1 Understanding Clinical Equivalence Review Requirements from Directives
More informationManagement of Hemophilia under Limited Resources
Management of Hemophilia under Limited Resources Ampaiwan Chuansumrit, M.D. ISTH Advanced Training Course International Hemophilia Training Center-Bangkok Faculty of Medicine Ramathibodi Hospital, Mahidol
More informationA COMPARISON OF FIBRIN GLUE WITH SUTURES FOR CONJUNCTIVAL AUTOGRAFTS IN PTERYGIUM EXCISION SURGERY. Lara Sandri
A COMPARISON OF FIBRIN GLUE WITH SUTURES FOR CONJUNCTIVAL AUTOGRAFTS IN PTERYGIUM EXCISION SURGERY Lara Sandri A dissertation submitted to the Faculty of Health Sciences, University of the Witwatersrand,
More informationA Primer for budding entrepreneurs: I think I have a great idea, now what? Background on Confluent The Primer Discussion
A Primer for budding entrepreneurs: I think I have a great idea, now what? Background on Confluent The Primer Discussion Company Overview Platform technology of in situ polymerized biomaterials and delivery
More informationHistoacryl Flexible Improved closure of surgical incisions
Improved closure of surgical incisions Closure Technologies Improved closure of surgical incisions New NEW! The new generation of Histoacryl glue has been designed to close and protect surgical wounds.
More informationAVOIDING ANTICOAGULATION in CRRT: An update on EMERGING MEMBRANES Available in 2012
AVOIDING ANTICOAGULATION in CRRT: An update on EMERGING MEMBRANES Available in 2012 1.-Rationale of Using Those Membranes 4.-Comparison with Other Strtegies 2.- When Should we Use Those? 5.- Remaining
More informationThe Lancet Publishes Results from the Landmark Phase III Rivaroxaban Study RECORD2
News Release Bayer HealthCare AG Corporate Communications 51368 Leverkusen Germany Phone +49 214 30 1 www.news.bayer.com Venous Blood Clot Prevention after Hip Replacement Surgery: The Lancet Publishes
More informationPerspective on initial Limflow experience in the US. Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii
Perspective on initial Limflow experience in the US Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii Disclosure Peter A. Schneider Potential conflicts of interest to report: Enter patients
More informationSynthesis and Characterization of Biodegradable Hemostat Gelatin Sponge for Surgery Application
R Iranian Journal of Pharmaceutical Sciences Summer 2008: 4(3): 193-200 www.ijps.ir Original Article Synthesis and Characterization of Biodegradable Hemostat Gelatin Sponge for Surgery Application Rana
More informationThoracoscopic Pneumonectomy. 10 th Annual Masters in Minimally Invasive Thoracic Surgery
Thoracoscopic Pneumonectomy 10 th Annual Masters in Minimally Invasive Thoracic Surgery September 22-23, 2017 Thomas A. D Amico MD Gary Hock Professor of Surgery Section Chief, Thoracic Surgery, Duke University
More informationDescription. Used materials. Warnings and precautions
USER MANUAL Description The GPS II System separates the blood components, present in blood, on the basis of density, through application of the GPS -Thermo International Equipment Company (IEC)-Centrifuge.
More informationThe terms ptosis, mastopexy, breast hypertrophy, COSMETIC
COSMETIC A Process for Quantifying Aesthetic and Functional Breast Surgery: II. Applying Quantified Dimensions of the Skin Envelope to Design and Preoperative Planning for Mastopexy and Breast Reduction
More informationDesign and Development of Biomedical and Surgical Instruments in Biomedical Applications
Chapter XX Design and Development of Biomedical and Surgical Instruments in Biomedical Applications Jeremy (Zheng) Li Additional information is available at the end of the chapter http://dx.doi.org/0./chapterdoi
More informationCategory Storage Shelf Life Additional Criteria
CE Update [blood banking/transfusion medicine] Blood Components for Hemostasis Jun Teruya, MD, DSc, and Glenn Ramsey, MD From the Department of Pathology, Northwestern University Medical School, Chicago.
More informationResident Job Analysis: Foundation for Selection & Evaluation
Resident Job Analysis: Foundation for Selection & Evaluation Authors: Janine C. Edwards, PhD; Marianne Currie, PhD; Terrance P. Wade, MD; Donald L. Kaminiski, MD Presenter: Janine C. Edwards, PhD Professor
More informationRegenKit THT. Autologous Platelet Rich Plasma (A-PRP) Reference Guide. Biologics. Concentrated on Healing
RegenKit THT Autologous Platelet Rich Plasma (A-PRP) Reference Guide Biologics Concentrated on Healing Step I: Collect Whole Blood RegenKit THT Simple 4-Step Process e single use RegenKit THT is designed
More informationNORTHERN OHIO FOUNDATION
NORTHERN OHIO FOOT & ANKLE FOUNDATION TheNorthernOhioFootandAnkleJournal OfficialPublicationoftheNOFAFoundation Topical Hemostatic Agents: A Review of the Literature Author: Jacqueline Morrison DPM 1 The
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT EVICEL solutions for sealant 2. QUALITATIVE AND QUANTITATIVE COMPOSITION The active ingredients are as follows: Component 1
More informationRepliform. Tissue Regeneration Matrix. Instructions for Use. Distributed by:
Repliform Tissue Regeneration Matrix Instructions for Use Distributed by: Boston Scientific Corporation 300 Boston Scientific Way Marlborough, MA 01752 Processed from Donated Human Tissue by: LifeCell
More informationQuantitative Assessment of Serum Nickel and Chromium Levels in Orthodontic Patients: An in vitro Study
10.5005/jp-journals-10021-1045 ORIGINAL ARTICLE Quantitative Assessment of Serum Nickel and Chromium Levels in Orthodontic Patients: An in vitro Study 1 Rohan Rai, 2 V Surendra Shetty, 3 Rajiv Ahluwalia,
More informationIntroduction Hemostasis: Tourniquet Test & Bleeding Time. Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO
Introduction Hemostasis: Tourniquet Test & Bleeding Time Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO Hemostasis A series of reactions that function to stop bleeding, maintaining
More informationFactor VIII Concentrate Factor IX Complex (Coagulation Factors, II, VII, IX, X) Concentrate
Factor VIII Concentrate Factor IX Complex (Coagulation Factors, II, VII, IX, X) Concentrate Application for retention on the WHO Model List From: Plasma Protein Therapeutics Association (PPTA) 1. Summary
More information